Glycyrrhiza glabra L. Extracts and Other Therapeutics against SARS-CoV-2 in Central Eurasia: Available but Overlooked.
Favipiravir didn't work against SARS-CoV-2, but Cridanimod showed promising results in suppressing its replication. Tilorone stimulated replication, while licorice extract inhibited replication but with low activity. Cridanimod is a potential candidate for clinical trials, while licorice extract could be further developed as a safe adjunctive therapy.
- Zhurinov MZ et al (2023).
- Molecules.
- PubMed:
- 37630394